Summary
Jingwen Yin is a director and molecular engineering leader with nine years of R&D experience bridging synthetic biology, virology, and biologics design, currently leading teams at Harbour BioMed in San Diego. She brings deep hands-on expertise in nanoantibody/scFv engineering, virus vector production (AAV, adenovirus, lentivirus), gene editing (CRISPR, TALEN, PiggyBac) and advanced protein/DNA interaction assays, backed by a PhD from the Chinese Academy of Sciences. A prolific experimentalist and communicator, she has six first-author publications, an invention patent, and experience scaling mid-to-high throughput screens from her oncolytic adenovirus work at Iconovir. Colleagues know her for creative molecular design, rigorous quantitative analysis, and an eagerness to translate early-stage lab insights into therapeutic programs. An unspoken strength: she pairs classic wet-lab craftsmanship (Gibson/Golden Gate cloning, protein purification) with NGS and microscopy fluency, enabling rapid iteration between design and validation.
9 years of coding experience
3 years of employment as a software developer
Doctor of Philosophy (Ph. D) Molecular Biology and Biochemistry, Doctor of Philosophy (Ph. D) Molecular Biology and Biochemistry at Chinese Academy of Sciences (Shanghai institute of biochemistry and cell biology)
Bachelor's degree Bio-pharmaceutical Engineering, Bachelor's degree Bio-pharmaceutical Engineering at Jilin University
English, Chinese